Hetmann_2023_Sci.Rep_13_11783

Reference

Title : Identification and validation of fusidic acid and flufenamic acid as inhibitors of SARS-CoV-2 replication using DrugSolver CavitomiX - Hetmann_2023_Sci.Rep_13_11783
Author(s) : Hetmann M , Langner C , Durmaz V , Cespugli M , Kochl K , Krassnigg A , Blaschitz K , Groiss S , Loibner M , Ruau D , Zatloukal K , Gruber K , Steinkellner G , Gruber CC
Ref : Sci Rep , 13 :11783 , 2023
Abstract : Hetmann_2023_Sci.Rep_13_11783
ESTHER : Hetmann_2023_Sci.Rep_13_11783
PubMedSearch : Hetmann_2023_Sci.Rep_13_11783
PubMedID: 37479788

Related information

Citations formats

Hetmann M, Langner C, Durmaz V, Cespugli M, Kochl K, Krassnigg A, Blaschitz K, Groiss S, Loibner M, Ruau D, Zatloukal K, Gruber K, Steinkellner G, Gruber CC (2023)
Identification and validation of fusidic acid and flufenamic acid as inhibitors of SARS-CoV-2 replication using DrugSolver CavitomiX
Sci Rep 13 :11783

Hetmann M, Langner C, Durmaz V, Cespugli M, Kochl K, Krassnigg A, Blaschitz K, Groiss S, Loibner M, Ruau D, Zatloukal K, Gruber K, Steinkellner G, Gruber CC (2023)
Sci Rep 13 :11783